Showing results (21-30 of 23) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Blood Advances|April 24, 2020
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host diseaseMark A Schroeder, H Jean Khoury, Madan Jagasia, et al.The Lancet. Oncology|June 24, 2010
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trialRoy S Herbst, Yan Sun, Wilfried E E Eberhardt, et al.The Lancet. Rheumatology|April 4, 2022
Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trialMeiLan K Han, Martti Antila, Joachim H Ficker, et al.Pageof 3